{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-067546","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.752278+00:00","generated_at":"2026-05-16T00:49:30.907785+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaxcyte enters $500M at-the-market equity offering; terminates prior $270.3M ATM with Jefferies","bullets":["Sales agreement with Leerink Partners for up to $500M in common stock via at-the-market offerings.","Placement agent receives up to 3.00% compensation on gross proceeds from sales.","Terminated prior sales agreement with Jefferies under which $270.3M had been sold.","Company not obligated to sell any shares; no assurance of any sales under new agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-067546","json":"https://secwatch.observer/filing/0001193125-26-067546.json","markdown":"https://secwatch.observer/filing/0001193125-26-067546.md","text":"https://secwatch.observer/filing/0001193125-26-067546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526067546/0001193125-26-067546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526067546/d259722d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:49:30.907785+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}